Viridian Therapeutics, Inc.\DE (VRDN) EBIT Margin Growth (3y) (2016 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | -843,732.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -843,732.00 |
| Dec 31, 2025 | -4.63 Mn |
| Sep 30, 2025 | 243,577.00 |
| Jun 30, 2025 | -13.08 Mn |
| Mar 31, 2025 | -11.84 Mn |
| Dec 31, 2024 | -10.79 Mn |
| Sep 30, 2024 | -9.03 Mn |
| Jun 30, 2024 | -9.86 Mn |
| Mar 31, 2024 | -7.64 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Jun 30, 2023 | -7.85 Mn |
| Mar 31, 2023 | -7.30 Mn |
| Sep 30, 2022 | -160,143.00 |
| Jun 30, 2022 | -1.13 Mn |
| Mar 31, 2022 | -883,081.00 |
| Dec 31, 2021 | -1.14 Mn |
| Sep 30, 2021 | -582,581.00 |
| Jun 30, 2021 | -124,510.00 |
| Mar 31, 2021 | -117,947.00 |
| Dec 31, 2020 | -16.72 Mn |